Alberta Faces Urgent Need for Improved Alzheimer’s Care

Patients and healthcare providers in Alberta are confronting a critical moment in the treatment of Alzheimer’s disease. Recent developments in dementia therapies could reshape the future of care, yet the region’s health system struggles to adapt. With a projected increase of 286 percent in dementia cases from 2020 to 2050, immediate action is necessary to address this growing challenge.

Historically, the response to patients questioning their cognitive health has often been a hesitant, “let’s wait and see.” As a family physician with over 30 years of experience, Dr. Richard Ward frequently encounters concerns from patients asking, “Am I getting dementia or just getting old?” Until recently, there were limited options for early diagnosis and treatment of Alzheimer’s, the most prevalent form of dementia.

The landscape is changing, however. For the first time in decades, new disease-modifying treatments have emerged that can delay the progression of Alzheimer’s. These therapies are designed to slow the disease’s impact, preserving cognitive function and independence for patients when initiated during the early stages. Currently approved in 44 countries, these promising options have not yet received approval from Health Canada, leaving many Canadian patients without access.

The urgency of this approval process is underscored by the nature of Alzheimer’s. The effectiveness of these therapies diminishes significantly once a patient progresses beyond the early stages of the disease. This creates a frustrating situation for patients and healthcare providers alike, raising the question of why dementia treatment approval lags behind other critical health issues such as cancer, heart disease, and diabetes.

In Alberta, the challenges are particularly pronounced. The province faces not only a rising number of dementia cases but also a significant increase in young-onset dementia, with cases expected to double from 2,700 in 2020 to 5,600 by 2050. Yet, the healthcare system is ill-equipped to meet the needs of this diverse and expanding population.

To effectively address these challenges, a paradigm shift in the approach to Alzheimer’s care is essential. This begins with empowering patients to recognize early signs of cognitive decline. Education is key; patients must understand when to suspect that memory problems may indicate early Alzheimer’s. Concurrently, family physicians and nurse practitioners require the tools and resources necessary to accurately identify and diagnose these conditions.

Alberta has a unique opportunity to lead in the advancement of Alzheimer’s care. As the science of dementia treatment progresses, it is imperative that the health system evolves in tandem. By prioritizing early diagnosis and facilitating access to effective treatments, Alberta can improve outcomes for countless individuals and families affected by Alzheimer’s.

Dr. Ward advocates for a collaborative approach to enhance the response to Alzheimer’s, emphasizing the importance of recognizing early signs and ensuring that healthcare professionals are equipped to make timely diagnoses. With the right strategies in place, Alberta could set a benchmark for dementia care, transforming the lives of those affected by this challenging disease.